Amy Racine

Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

George D. Demetri, Yanfeng Wang, Elisabeth Wehrle et al. · Journal of Clinical Oncology · 2009 · 401 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts

Frank Bretz, Heinz Schmidli, Franz König et al. · Biometrical Journal · 2006 · 270 citations

Medicine, Pharmacology, Clinical Pharmacology +6

Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group

Ian Judson, Peiming Ma, Bin Peng et al. · Cancer Chemotherapy and Pharmacology · 2004 · 191 citations

Pharmacy, Oncology, Pharmacokinetics +7

Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry

Amy Racine, Andrew P. Grieve, H. Flühler et al. · Journal of the Royal Statistical Society Series C (Applied Statistics) · 1986 · 173 citations

Computing, Pharmaceutical Analysis, Bayesian Biostatistics +11

Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations

Heinz Schmidli, Frank Bretz, Amy Racine et al. · Biometrical Journal · 2006 · 128 citations

Public Health, Biostatistics, Evidence-based Practice +16